DE69839993D1 - Probiotisches milchsäurebakterium zur behandlung bakterieller infektionen in zusammenhang mit sids - Google Patents

Probiotisches milchsäurebakterium zur behandlung bakterieller infektionen in zusammenhang mit sids

Info

Publication number
DE69839993D1
DE69839993D1 DE69839993T DE69839993T DE69839993D1 DE 69839993 D1 DE69839993 D1 DE 69839993D1 DE 69839993 T DE69839993 T DE 69839993T DE 69839993 T DE69839993 T DE 69839993T DE 69839993 D1 DE69839993 D1 DE 69839993D1
Authority
DE
Germany
Prior art keywords
sids
probiotic
treatment
bacterial infections
acid bacterium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69839993T
Other languages
English (en)
Inventor
Sean Farmer
Robert J Mikhail
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ganeden Biotech Inc
Original Assignee
Ganeden Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ganeden Biotech Inc filed Critical Ganeden Biotech Inc
Application granted granted Critical
Publication of DE69839993D1 publication Critical patent/DE69839993D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/1203—Addition of, or treatment with, enzymes or microorganisms other than lactobacteriaceae
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DE69839993T 1997-06-03 1998-06-03 Probiotisches milchsäurebakterium zur behandlung bakterieller infektionen in zusammenhang mit sids Expired - Lifetime DE69839993D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4845297P 1997-06-03 1997-06-03
PCT/US1998/011347 WO1998054982A1 (en) 1997-06-03 1998-06-03 Probiotic lactic acid bacterium to treat bacterial infections associated with sids

Publications (1)

Publication Number Publication Date
DE69839993D1 true DE69839993D1 (de) 2008-10-23

Family

ID=21954662

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69839993T Expired - Lifetime DE69839993D1 (de) 1997-06-03 1998-06-03 Probiotisches milchsäurebakterium zur behandlung bakterieller infektionen in zusammenhang mit sids

Country Status (11)

Country Link
EP (1) EP0986314B1 (de)
JP (2) JP2002502430A (de)
AT (1) ATE407687T1 (de)
AU (1) AU750136B2 (de)
CA (1) CA2292536A1 (de)
CY (1) CY1108646T1 (de)
DE (1) DE69839993D1 (de)
DK (1) DK0986314T3 (de)
ES (1) ES2317666T3 (de)
PT (1) PT986314E (de)
WO (1) WO1998054982A1 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6716435B1 (en) 1997-04-18 2004-04-06 Ganeden Biotech, Inc. Absorbent product containing absorbent structure and Bacillus coagulans
WO2001034168A1 (en) * 1999-11-08 2001-05-17 Ganeden Biotech, Inc. Inhibition of pathogens by bacillus coagulans strains
US6645506B1 (en) 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
US8563522B2 (en) 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
US7767203B2 (en) 1998-08-07 2010-08-03 Ganeden Biotech, Inc. Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
EP1719518A1 (de) * 1998-08-07 2006-11-08 Ganeden Biotech, Inc. Zusammensetzung enthaltend Bacillus Coagulans zur Erhöhung der Löslichkeit von Mineralien
EP1102595A2 (de) * 1998-08-07 2001-05-30 Ganeden Biotech, Inc. Methoden zur erhöhung der löslichkeit von nahrungsstoffen mit probiotisch wirksamen milchsäure-produzierenden bakterien
US6461607B1 (en) * 1998-08-24 2002-10-08 Ganeden Biotech, Inc. Probiotic, lactic acid-producing bacteria and uses thereof
JP4636637B2 (ja) * 1999-04-16 2011-02-23 アルテイメイト・コーポレーション 画質改善のためのエッジ画像向上補正
US6849256B1 (en) 1999-11-08 2005-02-01 Ganeden Biotech Incorporated Inhibition of pathogens by probiotic bacteria
JP2002255834A (ja) * 2001-03-05 2002-09-11 Calpis Co Ltd バクテリアル・トランスロケーション抑制剤及びバクテリアル・トランスロケーション抑制方法
US20060198817A1 (en) 2002-11-26 2006-09-07 Alverdy John C Materials and methods for preventing and treating microbe-mediated epithelial disorders
CA2559183A1 (en) * 2003-03-11 2004-09-23 Inatech International Inc. Probiotic micro-organisms and uses thereof
JP4782385B2 (ja) * 2003-05-29 2011-09-28 昭和産業株式会社 免疫賦活剤
CA2541753A1 (en) * 2003-07-10 2005-01-20 Michelle Alfa Combination therapy for gastroenteric diseases caused by microorganisms
US7731976B2 (en) 2003-08-29 2010-06-08 Cobb And Company, Llp Treatment of irritable bowel syndrome using probiotic composition
US7759105B2 (en) * 2003-08-29 2010-07-20 Cobb & Company, Llp Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
US8192733B2 (en) 2003-08-29 2012-06-05 Cobb & Associates Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
US7749509B2 (en) 2003-08-29 2010-07-06 Cobb And Company, Llp Treatment of autism using probiotic composition
EP2033529B1 (de) * 2003-10-24 2019-12-11 N.V. Nutricia Synbiotische Zusammensetzung für Kleinkinder
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US8894991B2 (en) 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US20050152884A1 (en) 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US7854927B2 (en) * 2004-05-11 2010-12-21 Ganeden Biotech, Inc. Methods and compositions for the dietary management of autoimmune disorders
EP2261323A1 (de) 2005-05-31 2010-12-15 The Iams Company Probiotische Katzen-Laktobazillen
PL1885383T3 (pl) 2005-05-31 2017-06-30 Iams Europe B.V. Kocie probiotyczne bifidobakterie
WO2007038466A2 (en) 2005-09-27 2007-04-05 Cobb & Company Treatment of bipolar disorder utilizing anti-fungal compositions
WO2008093303A2 (en) 2007-02-01 2008-08-07 The Iams Company Method for decreasing inflammation and stress in a mammal using glucose antimetaboltes, avocado or avocado extracts
AU2015200006B2 (en) * 2007-08-29 2016-12-01 Ganeden Biotech, Inc. Baked Goods
PT2211626T (pt) * 2007-08-29 2019-10-01 Ganeden Biotech Inc Produtos cozinhados em forno
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
CA2740423C (en) * 2008-10-16 2020-09-08 Ganeden Biotech, Inc. Probiotic grain-based compositions
ES2639364T3 (es) 2009-04-29 2017-10-26 Ganeden Biotech, Inc. Formulación de membrana celular bacteriana
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
WO2012135499A1 (en) 2011-03-31 2012-10-04 Ganeden Biotech, Inc. Probiotic sports nutrition compositions
US20150044317A1 (en) * 2012-02-28 2015-02-12 Ganeden Biotech, Inc. Topical Compositions for Reducing Visible Signs of Aging and Methods of Use Thereof
US10235383B2 (en) 2012-12-19 2019-03-19 Box, Inc. Method and apparatus for synchronization of items with read-only permissions in a cloud-based environment
US9596861B2 (en) * 2013-12-24 2017-03-21 Sami Labs Limited Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof
US20160353774A1 (en) * 2015-06-02 2016-12-08 Mead Johnson Nutrition Company Nutritional compositions comprising spore-forming probiotics
EP3635092A4 (de) * 2017-06-09 2021-02-24 Sami Labs Limited Zusammensetzungen und verfahren zur reduzierung von flatulenz
TR2022004759A2 (tr) * 2022-03-28 2022-04-21 Sayar Organik Biyolojik Ueruenler Imalat Sanayi Ve Ticaret Ltd Sirketi Bacillus subtilis bakteri̇ ai̇lesi̇ i̇çeri̇kli̇ bi̇yoteknoloji̇k ürün

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63317055A (ja) * 1987-06-18 1988-12-26 Seinosuke Ueda 食品素材の製造法
US5202241A (en) * 1988-09-09 1993-04-13 Gruppo Lepetit S.P.A. Antibiotic GE 2270
JPH06113823A (ja) * 1991-09-18 1994-04-26 Horinouchi Kanzume Kk 生菌数検出用培地及び検出方法
IT1262927B (it) * 1992-01-14 1996-07-22 Consiglio Nazionale Ricerche Batteri sporgenti e loro impiego come probiotici
US5242938A (en) * 1992-08-27 1993-09-07 Merck & Co., Inc. Derivatives of virginiamycin M1
WO1994011492A1 (en) * 1992-11-12 1994-05-26 Chr. Hansen's Laboratory, Inc. Method of favorably modifying poultry intestinal microflora
AUPM864894A0 (en) * 1994-10-07 1994-11-03 Borody, Thomas Julius Treatment of bowel-dependent neurological disorders
RU2067616C1 (ru) * 1995-04-25 1996-10-10 Научно-производственное объединение "Иммунопрепарат" Штамм бактерий bacillus subtilis, несущий свойство антибиотикорезистентности, используемый для получения препарата "бактиспорин"
FI104465B (fi) * 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
SE513815C2 (sv) * 1995-08-25 2000-11-06 Wasa Medicals Ab Förfarande för framställning av tabletter innehållande levande mikroorganismer och med oligosacharider i tablettmaterialet

Also Published As

Publication number Publication date
EP0986314B1 (de) 2008-09-10
EP0986314A4 (de) 2004-01-21
WO1998054982A1 (en) 1998-12-10
ATE407687T1 (de) 2008-09-15
CY1108646T1 (el) 2014-04-09
DK0986314T3 (da) 2009-01-19
CA2292536A1 (en) 1998-12-10
EP0986314A1 (de) 2000-03-22
JP2009269925A (ja) 2009-11-19
AU750136B2 (en) 2002-07-11
PT986314E (pt) 2008-12-30
JP2002502430A (ja) 2002-01-22
AU7719698A (en) 1998-12-21
ES2317666T3 (es) 2009-04-16

Similar Documents

Publication Publication Date Title
DE69839993D1 (de) Probiotisches milchsäurebakterium zur behandlung bakterieller infektionen in zusammenhang mit sids
EP1816190B1 (de) Als Probiotikum verwendbares neues Milchsäurebakterium
Angelakis et al. Related actions of probiotics and antibiotics on gut microbiota and weight modification
AlGburi et al. Safety properties and probiotic potential of Bacillus subtilis KATMIRA1933 and Bacillus amyloliquefaciens B-1895
ATE290391T1 (de) Orale verabreichung von laktobacillus zur behandlung und prävention von urogenitalen infektionen
DE60137235D1 (de) L. salivarius-Stamm enthaltende probiotische Produkte
HUP0200205A2 (hu) Tejsavbaktérium-törzsek hasmenés megelőzésére
HUP0200206A2 (hu) Tejsavbaktérium-törzsek hasmenés megelőzésére
ATE323503T1 (de) Bacillus coagulans-zusammensetzung und deren verwendung
WO2001058465A3 (en) Probiotic therapy for newborns
TW200514847A (en) Lactic acid bacteria having mucosal immunopotentiation effect
BR0314511A (pt) Seleção e uso de bactérias de ácido lático para reduzir a inflamação causada por helicobater
AU2018282018B2 (en) Compositions and methods for reducing flatulence
Weese et al. Screening of the equine intestinal microflora for potential probiotic organisms
EP2349295B1 (de) Pharmazeutische zusammensetzungen mit einer kombination aus streptokokken- und laktobazillenstämmen
Gonzalez et al. Biotherapeutic role of fermented milk
WO2000007606A3 (en) Methods for increasing the solubility of nutritional materials using probiotic lactic acid-producing bacteria
DE69622855D1 (de) Pharmazeutische zusammensetzungen welche lactobacillus plantarum und arginin beinhalten
Sen et al. Molecular characterization and in vitro analyses of a sporogenous bacterium with potential probiotic properties
EP1782818B1 (de) Pharmazeutische Zusammensetzung enthaltend Bacillus Coagulans und Simethicon zur Behandlung von gastrointestinalen Störungen
Szymański et al. Colonisation of the gastrointestinal tract by probiotic L. rhamnosus strains in acute diarrhoea in children
KR20180031247A (ko) 유산균 함유 건강보조식품
Hayes et al. Bacterial diversity in dried colostrum and whey sold as nutraceutical products
BR0012973B1 (pt) Uso de bactéria do ácido láctico pertencente ao gênero Bifidobacterium, e composição alimentícia ou farmacêutica.
Bezirtzoglou et al. Regulation of the bacterial intestinal implantation in infant born by caesarian section

Legal Events

Date Code Title Description
8364 No opposition during term of opposition